Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogues for patients at risk for renal failure after liver transplantation
This article is protected by copyright. All rights reserved. (Source: Transplant International)
Source: Transplant International - January 23, 2018 Category: Transplant Surgery Authors: Rob Bielen, Geert Robaeys, Sigrid Schelfhout, Diethard Monbaliu, Schalk Van der Merwe, Jacques Pirenne, Frederik Nevens Tags: Original Article Source Type: research
Impact of anti ‐HCV direct antiviral agents on graft function and immunosuppressive drug levels in kidney transplant recipients: a call to attention in the mid‐term follow‐up
This article is protected by copyright. All rights reserved. (Source: Transplant International)
Source: Transplant International - January 22, 2018 Category: Transplant Surgery Authors: Mario Fern ández‐Ruiz, Natalia Polanco, Ana García‐Santiago, Raquel Muñoz, Ana M. Hernández, Esther González, Verónica R. Mercado, Inmaculada Fernández, José María Aguado, Manuel Praga, Amado Andrés Tags: Original Article Source Type: research
Outcomes of kidney transplantations in children weighing 15 kilograms or less: a retrospective cohort study
Transplant International, EarlyView. (Source: Transplant International)
Source: Transplant International - January 19, 2018 Category: Transplant Surgery Source Type: research
---
Transplant International, Ahead of Print. (Source: Transplant International)
Source: Transplant International - January 19, 2018 Category: Transplant Surgery Source Type: research
Inflammatory and related biomarkers are associated with post ‐transplant diabetes mellitus in kidney recipients
This article is protected by copyright. All rights reserved. (Source: Transplant International)
Source: Transplant International - January 17, 2018 Category: Transplant Surgery Authors: Torbj ørn F Heldal, Thor Ueland, Trond Jenssen, Anders Hartmann, Anna V Reisæter, Pål Aukrust, Annika Michelsen, Anders Åsberg Tags: Original Article Source Type: research
Impact of antiviral prophylaxis in adults Epstein –Barr Virus‐seronegative kidney recipients on early and late post‐transplantation lymphoproliferative disorder onset: a retrospective cohort study
Transplant International, EarlyView. (Source: Transplant International)
Source: Transplant International - January 16, 2018 Category: Transplant Surgery Source Type: research
---
Transplant International, Ahead of Print. (Source: Transplant International)
Source: Transplant International - January 16, 2018 Category: Transplant Surgery Source Type: research
Are kidney transplantation outcomes improved in children weighting 15 kilograms or less in the last decades?
This article is protected by copyright. All rights reserved. (Source: Transplant International)
Source: Transplant International - January 16, 2018 Category: Transplant Surgery Authors: George S Reusz, Miklos Z Molnar Tags: Invited Commentary Source Type: research
Pre ‐transplant depression in lung recipients – a lost battle?
This article is protected by copyright. All rights reserved. (Source: Transplant International)
Source: Transplant International - January 16, 2018 Category: Transplant Surgery Authors: Ivan Knezevic, Bojan Zalar Tags: Invited Commentary Source Type: research
Early failure of kidney transplants in the current era – a national cohort study
This article is protected by copyright. All rights reserved. (Source: Transplant International)
Source: Transplant International - January 16, 2018 Category: Transplant Surgery Authors: Ilkka Helanter ä, Juulia Räihä, Patrik Finne, Marko Lempinen Tags: Original Article Source Type: research
Impact of antiviral prophylaxis in adults Epstein –Barr Virus‐seronegative kidney recipients on early and late post‐transplantation lymphoproliferative disorder onset: a retrospective cohort study
Summary
Post‐transplantation lymphoproliferative disorder (PTLD) pathogenesis is related to EBV infection. Mismatch with the donor (EBV D+/R−) is the main risk factor for both early PTLD (<1 year post‐transplantation) and late (>1 year). In these at‐risk patients, the role of antiviral prophylaxis for preventing PTLD remains controversial. We analyzed the impact of antiviral drugs given to prevent CMV disease in a monocentric retrospective cohort of 73 adult kidney or kidney–pancreas EBV‐seronegative recipients, transplanted between 01/01/2000 and 01/01/2016. Thirty‐seven (50.7%, prophylaxis group) rece...
Source: Transplant International - January 16, 2018 Category: Transplant Surgery Authors: Simon Ville, Berthe ‐Marie Imbert‐Marcille, Marianne Coste‐Burel, Claire Garandeau, Aurélie Meurette, Diego Cantarovitch, Magali Giral, Maryvonne Hourmant, Gilles Blancho, Jacques Dantal Tags: Original Article Source Type: research
Clinical validation of a novel enzyme ‐linked immunosorbent spot assay‐based in vitro diagnostic assay to monitor cytomegalovirus‐specific cell‐mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study
This study aimed to evaluate the suitability of T‐Track® CMV, a novel IFN‐γ ELISpot assay based on the stimulation of peripheral blood mononuclear cells with pp65 and IE‐I CMV proteins, to monitor CMV‐CMI following kidney transplantation. A prospective longitudinal multicenter study was conducted in 86 intermediate‐risk renal transplant recipients. CMV‐CMI, CMV viral load, and clinical complications were monitored over 6 months post‐transplantation. Ninety‐five percent and 88–92% ELISpot assays were positive pre‐ and post‐transplantation, respectively. CMV‐specific response was reduced following ...
Source: Transplant International - January 16, 2018 Category: Transplant Surgery Authors: Bernhard Banas, Dominik Steubl, Lutz Renders, Dominik Chittka, Miriam C. Banas, Thomas Wekerle, Martina Koch, Oliver Witzke, Anja M ühlfeld, Claudia Sommerer, Antje Habicht, Christian Hugo, Thomas Hünig, Monika Lindemann, Traudel Schmidt, Anne Rascle, S Tags: Original Article Source Type: research
Rituximab as monotherapy for the treatment of chronic active antibody ‐mediated rejection after kidney transplantation
This article is protected by copyright. All rights reserved. (Source: Transplant International)
Source: Transplant International - January 12, 2018 Category: Transplant Surgery Authors: Yannick D. Muller, Ghaleb Nseir, Samuel Rotman, Julien Vionnet, Mathieu Halfon, Emmanuelle Catana, D éla Golshayan, Jean‐Pierre Venetz, Vincent Aubert, Manuel Pascual Tags: Letter to the Editor Source Type: research
Rituximab as monotherapy for the treatment of chronic active antibody ‐mediated rejection after kidney transplantation
Transplant International,Volume 31, Issue 4, Page 451-455, April 2018. (Source: Transplant International)
Source: Transplant International - January 12, 2018 Category: Transplant Surgery Source Type: research
